Proton therapy in children under three shows 85% two-year survival but substantial late toxicity
Among 76 children aged three years or younger, proton therapy achieved 85.2% two-year local control, with 14.9% severe late toxicity.
Among 76 children aged three years or younger, proton therapy achieved 85.2% two-year local control, with 14.9% severe late toxicity.
All 13 CNS germinoma patients remained event-free at five years after upfront RT, but treatment-sequencing comparisons in nongerminomatous tumors remain inconclusive.
All ten children completed upright proton therapy, including craniospinal irradiation, with no in-field progression at three months but limited long-term follow-up.
Blocking autophagy with hydroxychloroquine after growth plate irradiation increased skeletal growth deficits in mice, identifying a potential mechanism of radiation injury.
At 15 years, in-field second malignancy incidence was 0% after proton RT versus 11.1% after photons in 108 retinoblastoma patients.
Radiation-induced MRI enhancement occurred in 7.9% of children after proton therapy and spatially overlapped with elevated LET-associated biological dose.
Control, predictability, information and relational continuity emerged as key needs for making awake pediatric proton therapy more manageable.
MRI-based nnU-Net segmentation achieved Dice scores ≥0.90 and reduced clinical contouring workflow time by more than 50%.
A multidisciplinary roadmap defines the safety, imaging and research requirements needed before upright radiotherapy can be adopted more broadly in children.
A decade after the previous IAEA survey, access to modern paediatric radiotherapy improved, but substantial technology, imaging and workforce disparities remain.
Across 12 reported patients receiving at least three radiation courses for DIPG, median survival was 27 months with frequent symptomatic benefit.
VMAT-TBI achieved 96.6% mean PTV D95 while keeping mean lung and kidney doses below 9 Gy.
Across 27 years of COG trials, IMRT/VMAT replaced 3D photons while proton use expanded to nearly 40% of radiotherapy patients.
Behavioral and image-derived features explained 39% of interobserver contour uncertainty during manual brain tumor delineation.
Automated pediatric CSI contours achieved a mean Dice score of 0.959 and reduced target-delineation time from approximately eight hours to 30 minutes.